MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
The Motley Fool
January 2, 2004
Alyce Lomax
A Bitter Pill for Amerisource Veterans ditch Amerisource for rival; investors punish the entire pharmaceutical distribution industry. mark for My Articles similar articles
The Motley Fool
April 26, 2004
Alyce Lomax
Amerisource Hangs On While pharmaceutical distribution is an industry with obvious opportunities for financial reward, the potential for a price war remains a risk. mark for My Articles similar articles
The Motley Fool
July 1, 2004
W.D. Crotty
Drug Wholesalers Taking a Beating A sharp drop at drug wholesaler Cardinal Health provides a unique buying opportunity. mark for My Articles similar articles
The Motley Fool
February 13, 2004
Dave Marino-Nachison
Toro Tears Up Guidance Shares of lawn-equipment company Toro rose nearly 8% yesterday as investors digested the news release that bumped up fiscal first-quarter guidance. Management's original numbers seem strangely downbeat. mark for My Articles similar articles
The Motley Fool
February 23, 2004
Alyce Lomax
Onward, Coach! The retailer boosts guidance on a strong spring line and success in Japan. mark for My Articles similar articles
The Motley Fool
May 20, 2004
Tom Taulli
Cardinal Rules of M&A Cardinal Health is upbeat on its latest acquisition, but needs bigger deals to push growth. mark for My Articles similar articles
The Motley Fool
April 12, 2004
Seth Jayson
Gannett's Ad-vantageous Q1 First-quarter earnings for Gannett, publisher of USA Today and hundreds of other newspapers, show strong increases in advertising revenues across every segment of the company. mark for My Articles similar articles
The Motley Fool
October 25, 2004
Tom Taulli
McKesson Gets Pain Relief Drug distributors would like to forget 2004. But this may mean bargains for investors. mark for My Articles similar articles
The Motley Fool
November 9, 2005
W.D. Crotty
McKesson Fattens Its Margins The pharma distributor turns in an outstanding second quarter. Because McKesson is a broadly based supplier, it avoids the roller-coaster impact that specific drug successes and failures have on drug-developer stocks. mark for My Articles similar articles
The Motley Fool
April 5, 2004
Rick Aristotle Munarriz
Waiting for Yahoo! Something important is going to take place when Yahoo! reports its first-quarter earnings on Wednesday. Beyond that, it's going to be pretty quiet on the earnings front in the abridged trading week that lies ahead. mark for My Articles similar articles
The Motley Fool
May 6, 2008
Steven Renaldi
McKesson Garners Generic Growth New products offer the generic-drug distributor profit potential in a competitive industry. mark for My Articles similar articles
The Motley Fool
April 27, 2004
Phil Wohl
Verizon's Cloudy Horizon I guess it shouldn't come as a surprise that another telecom services company reported weak first-quarter earnings. The latest telecom to underwhelm the investment community was Verizon Communications, which reported first-quarter earnings today. mark for My Articles similar articles
The Motley Fool
May 11, 2004
W.D. Crotty
Boom Profits, Bust Prices Relatively staid Greek shipper Tsakos Energy Navigation just reported glamour-stock results. First-quarter revenue was up 43% and net income jumped 85%. Based on analyst estimates for 2004, the stock is trading at a rock-bottom 6.3 times forward earnings. mark for My Articles similar articles
The Motley Fool
April 15, 2004
Rich Smith
Texas Instruments Stands Out The chip maker distinguishes itself with solid Q1 results. mark for My Articles similar articles
The Motley Fool
November 7, 2007
Billy Fisher
Cardinal Has Its Wings Clipped Despite a healthy year-over-year pop of 15% in EPS from operations, much of the focus in the first-quarter was shifted to a weak performance by Cardinal's pharmaceutical services segment. mark for My Articles similar articles
The Motley Fool
May 17, 2004
Phil Wohl
Lowe's Keeps It Going The country's second-largest home-improvement retailer, Lowe's, reported first-quarter earnings today that signal strength in an industry nearing its peak. Can the home-improvement retailer continue to grow in all markets? mark for My Articles similar articles
The Motley Fool
March 11, 2004
Ben McClure
Quality Earnings Count Here are three telltale signs of strong earnings. This reporting period, it's worthwhile taking a peek behind the earnings. Here are three telltale signs of earnings "quality" to guide your stock picks. mark for My Articles similar articles
The Motley Fool
April 6, 2004
Brian Gorman
Kellogg's Great Start Kellogg served up some good news for shareholders yesterday, announcing that it is off to a "great start" for 2004 and expects first-quarter earnings to be up 30% from the $0.40 per share reported in the same period last year. mark for My Articles similar articles
BusinessWeek
August 30, 2004
Gene G. Marcial
PSS Is Really Delivering The Goods When David Smith took the CEO job at PSS World Medical in 2000, sales stood at $160 million. They've since rocketed to $1.35 billion. No wonder industry giants are eyeballing the company: They hope Smith will sell. mark for My Articles similar articles
The Motley Fool
December 18, 2003
Dave Marino-Nachison
Standing by Family Dollar Investors may be catching on to this discounted Dollar retailer. mark for My Articles similar articles
The Motley Fool
May 11, 2004
Alyce Lomax
Better Days for May? Is May Department Stores lagging the retail revolution -- or is it poised to benefit from a more wary consumer? mark for My Articles similar articles
BusinessWeek
May 17, 2004
Berner& Arndt
The Sales Engine Kicks In First-quarter earnings for the 900 companies in BusinessWeek's Corporate Scoreboard surged 25% from the year before. But what stood out even more was the Scoreboard's 12% increase in revenue, the largest gain in three years. mark for My Articles similar articles
The Motley Fool
October 8, 2007
Billy Fisher
McKesson Expands Its Empire A new acquisition strengthens the company's presence in the cancer drug market. Investors, take note. mark for My Articles similar articles
The Motley Fool
May 6, 2005
W.D. Crotty
McKesson's New Pep Pill The drug wholesaler reports strong fourth-quarter results as it moves to a fee-for-service model. mark for My Articles similar articles